Trial · NCT05687448
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 13 of 13
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Major Adverse Clinical Events (MACE) | Up to 3.5 months | The primary endpoint is a composite efficacy endpoint including death from any cause, myocardial infarction, stroke, systemic embolism, deep vein thrombosis, or pulmonary embolism and valve thrombosis. |
| Secondary | Bleeding | Up to 3.5 months | ISTH major and non-major clinically relevant bleeding |
| Secondary | Death | Up to 3.5 months | Including cardiovascular and non cardiovascular death |
| Secondary | Myocardial infarction | Up to 3.5 months | |
| Secondary | Stroke | Up to 3.5 months | |
| Secondary | Systemic embolism | Up to 3.5 months | |
| Secondary | Deep vein thrombosis or pulmonary embolism | Up to 3.5 months | |
| Secondary | Valve thrombosis | Up to 3.5 months | |
| Secondary | Bleeding | Up to 3.5 months | According to ISTH major and non-major clinically relevant bleeding, BARC and TIMI 6, BARC and TIMI Classifications |
| Secondary | Echographic parameter of aortic valve | Up to 3.5 months | Variation of mean aortic gradient (mm/Hg) |
| Secondary | Assessment of coagulation | Up to 3.5 months | Measured by thrombin generation in a subgroup population (n=216) |
| Secondary | To evaluate platelet activation (sP-selectin) in a subgroup population (n = 216) | Up to 3.5 months | |
| Secondary | To build a population PK/PD in the experimental group | Up to 3.5 months | Measuring the apixaban concentration (anti-Xa activity expressed in ng/mL) (apixaban, n = 108) |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05687448/registered